Fine-needle aspiration of metastatic clear cell carcinoma of the kidney: Employment of microdissection and the polymerase chain reaction as a potential diagnostic tool

Cancer

Volumn 81, Issue 3, 1997, Pages 180-186

  Beaty, Michael W ^a   Zhuang, Zhengping ^a   Park, W S ^a   Emmert Buck, Michael R ^a   Linehan, W Marston ^a   Lubensky, Irina A ^a   Abati, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Carcinoma; Clear cell; Fine needle aspiration; Loss of heterozygosity; Metastasis; Microdissection; Polymerase chain reaction; Renal cell; Von Hippel Lindau gene

Indexed keywords

ADULT; ARTICLE; ASPIRATION BIOPSY; CHROMOSOME MICRODISSECTION; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY METASTASIS; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADENOCARCINOMA, CLEAR CELL; ADULT; AUTORADIOGRAPHY; BIOPSY, NEEDLE; DNA, NEOPLASM; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; POLYMERASE CHAIN REACTION;

EID: 0031586047     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19970625)81:3<180::AID-CNCR8>3.0.CO;2-V     Document Type: Article

References (36)

1. Motzer RJ, Bander NH, Nanus DM. Renal-cell carcinoma. N Engl J Med 1996;335:865-75.
2. Cajulis RS, Katz RL, Dekmezian R, El-Naggar A, Ro JY. Fine needle aspiration biopsy of renal cell carcinoma. Acta Cytol 1993;37:367-72.
3. Nyguyen GK. Fine needle aspiration biopsy cytology of metastatic renal cell carcinoma. Acta Cytol 1988;32:409-14.
4. Domagala W, Lasota J, Wolska H, Lubinski J, Weber K, Osborn M. Diagnosis of metastatic renal cell and thyroid carcinomas by intermediate filament typing and cytology of tumor cells in fine needle aspirates. Acta Cytol 1988;32:415-21.
5. Saleh H, Masood S, Wynn G, Assaf N. Unsuspected metastatic renal cell carcinoma diagnosed by fine needle aspiration biopsy: a report of four cases with immunocytochemical contributions. Acta Cytol 1994;38:554-61.
6. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder, and related urinary structures. Fascicle 11. In: Atlas of tumor pathology. Washington, DC: Armed Forces Institute of Pathology; 1993:92-136.
7. Medeiros LJ, Michie SA, Johnson DE, Warnke RA, Weiss LM. An immunoperoxidase study of renal cell carcinomas. Hum Pathol 1988;19:980-7.
8. Wick MR, Chewitz DL, McGlennen RC, Dehner LP. Adrenocortical carcinoma: an immunohistochemical comparison with renal cell carcinoma. Am J Pathol 1986;122:343-52.
9. Wick MR, Cherwitz DL, Manivel JC, Sibley R. Immunohistochemical findings in tumors of the kidney. In: Edbl JN, editor. Tumors and tumor-like conditions of the kidneys and ureters. New York: Churchill Livingstone; 1990:207-47.
10. Anglard P, Tory K, Brauch GH, Latif F, Merino MJ, Lerman MI, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-7.
11. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994;7:85-90.
12. Zbar B, Brauch H, Talmage C, Linehan M. Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma. Nature 1987;327:721-4.
13. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
14. Dal Cin P, Sciot R, De Wever I, Van Damme B, Van Den Berghe H. Diagnosis of primary renal cell carcinoma in a left supraclavicular lymph node by chromosome analysis. J Urol 1996;156:171-2.
15. Gronwald J, Stsrkel S, Holtzgreve-Grez H, Hadaczek P, Brinkschmidt C, Jauch A, et al. Comparison of DNA gains and losses in primary clear cell carcinomas and metastatic sites: importance of 1q and 3p copy number changes in metastatic events. Cancer Res 1997;57:481-7.
16. Zhuang Z, Roth MJ, Emmert-Buck MR, Lubensky IA, Liotta LA, Solomon D. Detection of the von Hippel-Lindau gene deletion in cytologic specimens using microdissection and the polymerase chain reaction. Acta Cytol 1994;38:671-5.
17. Zhuang Z, Emmert-Buck MR, Roth MJ, Gnarra J, Linehan WM, Liotta LA, et al. Von Hippel-Lindau gene deletion detected in microdissected sporadic human colon carcinoma specimens. Hum Pathol 1996;27:152-6.
18. Zhuang Z, Bertheau P, Emmert-Buck MR, Liotta LA, Gnarra J, Linehan WM, et al. A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size. Am J Pathol 1995;146:620-5.
19. Orita M, Iwahara H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci U S A 1990;86:2766-70.
20. Chuaqui R, Vargas MP, Castigliomi T, Elsner B, Zhuang Z, Emmert-Buck M, et al. Detection of heterozygosity loss in microdissected fine needle aspiration specimens of breast carcinoma. Acta Cytol 1996;40:642-8.
21. Abati A, Liotta LA. Looking forward in diagnostic pathology: the molecular superhighway [editorial]. Cancer 1996;76:1-3.
22. Chen JT, Lane MA, Clark DP. Inhibitors of the polymerase chain reaction in Papanicolaou stain: removal with a simple destaining procedure. Acta Cytol 1996;40:873-7.
23. Gall K, Pavicic D, Pavelic J, Audy-Jurkovics, Pavelic K. PCR amplification of DNA from stained cytologic smears. J Clin Pathol 1993;46:378-9.
24. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, et al. Laser capture microdissection. Science 1996;274:998-1001.
25. Chen F, Kishida T, Duh FM, Renbaum P, Orcutt ML, Schmidt L, et al. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. Cancer Res 1995;55:4804-7.
26. Foster K, Osborne RJ, Huddart RA, Affara NA, Ferguson-Smith MA, Maher ER, et al. Molecular genetic analysis of the Von Hippel-Lindau disease (VHL) tumour suppressor gene in gonadal tumours. Eur J Cancer 1995;31A:2392-5.
27. Foster K, Crossey PA, Cairns P, Hetherington JW, Richards FM, Jones MH, et al. Molecular genetic investigation of sporadic renal cell carcinoma: analysis of allele loss on chromosome 3p, 5q, 11p, 17, and 22. Br J Cancer 1994;69:230-4.
28. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, et al. Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 1991;58:1080-96.
29. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994;91:9700-4.
30. Macdonald NJ, Steeg P. Molecular basis of tumour metastasis. Cancer Surv 1993;16:175-99.
31. Shekar PVM, Aslakson CJ, Miller FR. Molecular events in metastatic progression. Semin Cancer Biol 1993;4:193-204.
32. Usmani BA. Genomic instability and metastatic progression. Pathobiology 1993;61:109-16.
33. Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, et al. Genetic alterations during colorectal-rumor development. N Engl J Med 1988;319:525-32.
34. Knudson AG. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res 1985;45:1437-43.
35. Bugert P, Kovacs G. Molecular differential diagnosis of renal cell carcinomas by microsatellite analysis. Am J Pathol 1996;149:2081-8.
36. Steiner G, Sidransky D. Molecular differential diagnosis of renal cell carcinoma: from microscopes to microsatellites [commentary]. Am J Pathol 1996;149:1791-5.